Wei Liang
- Molecular Biology top 10%
- Nephrology top 2%
- Cancer Research top 10%
- Surgery
- Endocrinology, Diabetes and Metabolism top 10%
- Topics
- Renal Diseases and Glomerulopathies (9 papers)Chronic Kidney Disease and Diabetes (6 papers)Dialysis and Renal Disease Management (5 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Wei Liang
44 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 738
- Nephrology 322
- Cancer Research 199
- Surgery 147
- Endocrinology, Diabetes and Metabolism 142
Countries citing papers authored by Wei Liang
This map shows the geographic impact of Wei Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Liang more than expected).
Fields of papers citing papers by Wei Liang
This network shows the impact of papers produced by Wei Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Liang. The network helps show where Wei Liang may publish in the future.
Co-authorship network of co-authors of Wei Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Wei Liang. A scholar is included among the top collaborators of Wei Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Liang. Wei Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 42 | |
| 4 | 38 | |
| 5 | 8 | |
| 6 | 6 | |
| 7 | 22 | |
| 8 | 29 | |
| 9 | 21 | |
| 10 | 6 | |
| 11 | 3 | |
| 12 | 53 | |
| 13 | 24 | |
| 14 | 52 | |
| 15 | 19 | |
| 16 | 23 | |
| 17 | 19 | |
| 18 | 61 | |
| 19 | 42 | |
| 20 | 6 |
About Wei Liang
Wei Liang is a scholar working on Nephrology, Internal Medicine and Applied Microbiology and Biotechnology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (9 papers), Chronic Kidney Disease and Diabetes (6 papers) and Dialysis and Renal Disease Management (5 papers). The work is most often cited by research in Nephrology (322 citations), Clinical Biochemistry (106 citations) and Cancer Research (199 citations). Wei Liang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Guohua Ding, Jijia Hu, Jun Feng, Zhaowei Chen, Zijing Zhu, Yiqiong Ma, Wenrong Xu, Xu Zhang, Peng Zhang and Jingyan Chen. Their work appears in journals such as Nature Communications, Brain Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.